Health Catalyst (NASDAQ:HCAT) reported quarterly earnings of $0.02 per share which met the analyst consensus estimate. This is a 100 percent increase over earnings of $0.01 per share from the same period last year. The company reported quarterly sales of $70.756 million which beat the analyst consensus estimate of $69.171 million by 2.29 percent. This is a 10.90 percent decrease over sales of $79.413 million the same period last year.